2020
DOI: 10.1016/j.bcab.2020.101700
|View full text |Cite
|
Sign up to set email alerts
|

Prophylactic supplementation of sinapic acid ameliorates zoledronic acid induced changes in osteoblast survival and differentiation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 28 publications
0
3
0
Order By: Relevance
“…Sinapic acid is recognized as a potent antioxidant with osteogenic properties. Sadhasivam et al [35] discovered that zoledronic acid decreased osteoblast viability and inhibited differentiation. Conversely, treatment with sinapic acid led to an increase in the expression levels of osteoblast marker genes, including Runx2, Col-I, and ALP.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Sinapic acid is recognized as a potent antioxidant with osteogenic properties. Sadhasivam et al [35] discovered that zoledronic acid decreased osteoblast viability and inhibited differentiation. Conversely, treatment with sinapic acid led to an increase in the expression levels of osteoblast marker genes, including Runx2, Col-I, and ALP.…”
Section: Discussionmentioning
confidence: 99%
“…Conversely, treatment with sinapic acid led to an increase in the expression levels of osteoblast marker genes, including Runx2, Col-I, and ALP. Sinapic acid also promoted osteoblast differentiation and mineralization by enhancing calcium deposition [35]. Moreover, Sinapic acid-loaded chitosan scaffolds are used for bone regeneration [44] and phenolic compounds have the potential to prevent bone defects by modulating osteoblast activity [45].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation